MHRA authorises Diurnal’s CAH therapy Efmody

2nd July 2021 Uncategorised 0

Congenital adrenal hyperplasia (CAH) is a rare condition caused by deficiency of adrenal enzymes

More: MHRA authorises Diurnal’s CAH therapy Efmody
Source: News